JANEWAY and his associates1 in 1944 administered human albumin intravenously to two patients with hepatic cirrhosis, ascites and hypoalbuminemia and noted temporary improvement with control of ascites. Since that time, conflicting reports have appeared concerning the effects of human albumin in treatment of decompensated hepatic cirrhosis.2 The present study is concerned with the effects of intravenously administered salt-poor human albumin on the clinical courses of 34 patients, critically ill with cirrhosis of the liver, hypoalbuminemia and ascites. The substance was given in amounts sufficient to maintain a normal serum albumin concentration for extended periods. The results indicate that human albumin has a place in the therapy of such patients.
A. Techniques of Study.
—All patients were kept in bed until there was evidence of continuing clinical improvement. The dietary regimen was as follows: 140 Gm. of protein, 340 Gm. of carbohydrate and 110 Gm. of fat were
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 299
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.